Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair

While investigating the novel anticancer drug ecteinascidin 743 (Et743), a natural marine product isolated from the Caribbean sea squirt, we discovere d a new cell-killing mechanism mediated by DNA nucleotide excision repair ( NER). A cancer cell line selected for resistance to Et743 had chromosome al terations in a region that included the gene implicated in the hereditary d isease xeroderma pigmentosum (XPG, also known as Ercc5). Complementation wi th wild-type XPG restored the drug sensitivity. Xeroderma pigmentosum cells deficient in the NER genes XPG, XPA, XPD or XPF were resistant to Et743, a nd sensitivity was restored by complementation with wildtype genes. Moreove r, studies of cells deficient in XPC or in the genes implicated in Cockayne syndrome (CSA and CSS) indicated that the drug sensitivity is specifically dependent on the transcription-coupled pathway of NER. We found that Et743 interacts with the transcription-coupled NER machinery to induce lethal DN A strand breaks.